home / stock / nby / nby news


NBY News and Press, NovaBay Pharmaceuticals Inc. From 07/22/22

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...

NBY - Catalyst watch: Fed rate hike, new SPACs teed up and Amazon leads huge earnings rush

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...

NBY - NovaBay Pharmaceuticals' DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the availability of select DERMAdoctor products at two popular U.S. online retaile...

NBY - NovaBay Pharma reports record Avenova sales during Amazon's Prime Day event

NovaBay Pharma ( NYSE: NBY ) said on Thursday it had record sales of eyecare product Avenova during Amazon’s Prime Day event. The company said sales of Avenova-branded products during the two-day event increased 27% over Prime Days 2021 and 48% over Prime Days 2...

NBY - NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon's Prime Day Event

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces record sales of Avenova-branded products during Amazon’s Prime Day event (Ju...

NBY - NovaBay Pharmaceuticals' DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that its DERMAdoctor product collections will be featured at Cosmoprof North Ameri...

NBY - NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q1 2022 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Conference Call Participants Destiny Hance - Lade...

NBY - NovaBay GAAP EPS of $0.00 beats by $0.03, revenue of $2.63M misses by $0.63M

NovaBay press release (NYSE:NBY): Q1 GAAP EPS of $0.00 beats by $0.03. Revenue of $2.63M (+45.3% Y/Y) misses by $0.63M. For further details see: NovaBay GAAP EPS of $0.00 beats by $0.03, revenue of $2.63M misses by $0.63M

NBY - NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

Avenova ® Spray unit sales increased 15% with record-high units sold through the OTC channel Announced launch of two next-generation OTC DERMAdoctor products this week building on momentum of top-selling collections, bringing new OTC product introductions to five si...

NBY - Notable earnings after Thursday's close

AAIC, ACB, ACHV, AFRM, AGRO, AGRX, APDN, APTX, AQN, AVPT, AXU, BANX, BBI, BEAT, BIOL, BLBD, BLND, BOXL, BSQR, CBAY, CDXC, CLLS, CLVR, CODX, COMP, CORZ, CRMD, CTIC, CURI, CWCO, DARE, DUOL, EDR, ETON, EYEN, FIGS, GPL, GWH, HLI, HTGM, IBIO, IDN, OTCQB:IGXT, IMMR, INDI, INTZ, INUV, JOBY, KMPH, LC...

NBY - NovaBay introduces new skincare products with anti-aging formulations

NovaBay Pharmaceuticals (NYSE:NBY) said it expanded its top-selling Kakadu C and Calm Cool + Corrected product lines by introducing new products with anti-aging ingredients to help reduce the appearance of wrinkles, fine lines, pores and discoloration. "We've expanded two highly popular skinc...

Previous 10 Next 10